Lupin Pharmaceuticals, Inc. Enters Into Marketing Alliance with ASCEND Therapeutics, Inc. for Suprax(R) 400 mg Tablets in the U.S.
6/23/2008 10:15:15 AM
More...
|
Valeant Pharmaceuticals International (VRX) to Partner with ASCEND Therapeutics, Inc. to Promote Migranal(R) to OB/GYNs
10/2/2007 11:01:51 AM
More...
|
Columbia Laboratories, Inc. (CBRX) Signs U.S. License and Supply Agreement with ASCEND Therapeutics, Inc. to Market PROCHIEVE(R) 4% Progesterone Gel
9/27/2007 9:49:18 AM
More...
|
PDI, Inc. (PDII) Selected To Promote EstroGel(R) For ASCEND Therapeutics, Inc.
2/1/2006 10:21:37 AM
More...
|
ASCEND Therapeutics, Inc. Announces Results From Phase 2 Cyclic Breast Pain Study
10/19/2005 5:12:24 PM
More...
|
ASCEND Therapeutics, Inc. Raises Awareness Of Breast Pain And Density Concerns During National Women's Health Week
10/19/2005 5:11:15 PM
More...
|
ASCEND Therapeutics, Inc. Files Patent Applications For Drug Planned To Treat Benign Breast Disease
10/19/2005 5:11:00 PM
More...
|
ASCEND Therapeutics, Inc. Presents Results Of Phase 2 Clinical Trial For Cyclic Breast Pain; Company's Transdermal 4-OHT Therapy Was Well Tolerated And Reduced Breast Pain In Clinical Trial
10/19/2005 5:10:14 PM
More...
|
ASCEND Therapeutics, Inc.. Announces Formation Of Scientific Advisory Board
10/19/2005 5:09:58 PM
More...
|
ASCEND Therapeutics, Inc. Acquires North American Product Rights; New Estrogen Inhibitor In Phase II Clinical Development
10/19/2005 5:09:56 PM
More...
|
|